Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001911051-22-000003)

Filing Details

Accession Number:: 0001911051-22-000003
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-08-29 21:57:10
Reporting Period:: 2022-08-25

Accepted Time:: 2022-08-29 21:57:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
926617	Aspira Women's Health Inc.	AWH	In Vitro & In Vivo Diagnostic Substances (2835)	330595156

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1911051	Rachelle Celeste Fralick	C/O Aspira Women'S Health Inc. 12117 Bee Caves Rd, Bldg 3-100 Austin TX 78738		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-08-25	6,667	$0.00	102,945	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.001	Warrant (right to buy)	Acquisiton	2022-08-25	6,667	$0.00	6,667	$0.88

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,667	2022-08-25	2027-08-25	No	4	P	Direct

Footnotes

Each share of common stock was purchased together with one warrant to purchase one share of common stock (each share and related warrant, a "unit"), at a price of $0.75 per unit.
Total reflects the adjustment of 3,393 shares of common stock previously reported as part of a restricted stock unit grant made on March 31, 2022.